Articles

Sort by
Previous Page Page 1 of 2 Next Page
  1. Erratum

    Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana

    Dorcas Obiri-Yeboah, Yaw Adu-Sarkodie, Florencia Djigma, Kafui Akakpo, Ebenezer Aniakwa-Bonsu, Daniel Amoako-Sakyi, Jacques Simpore and Philippe Mayaud

    Gynecologic Oncology Research and Practice 2017 4:8

    Published on: 23 March 2017

    The original article was published in Gynecologic Oncology Research and Practice 2017 4:5

  2. Research

    Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial

    Palliative systemic treatment in elderly gynaecological cancer patients remains a major challenge. In recurrent ovarian cancer (ROC), treosulfan an active alkylating drug showed similar cytotoxicity whether as...

    Radoslav Chekerov, Philipp Harter, Stefan Fuxius, Lars Christian Hanker, Linn Woelber, Lothar Müller, Peter Klare, Wolfgang Abenhardt, Yoana Nedkova, Isil Yalcinkaya, Georg Heinrich, Harald Sommer, Sven Mahner, Pauline Wimberger, Dominique Koensgen-Mustea, Rolf Richter…

    Gynecologic Oncology Research and Practice 2017 4:6

    Published on: 7 March 2017

  3. Research

    Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana

    Modern cervical cancer screening increasingly relies on the use of molecular techniques detecting high-risk oncogenic human papillomavirus (hr-HPV). A major challenge for developing countries like Ghana has be...

    Dorcas Obiri-Yeboah, Yaw Adu-Sarkodie, Florencia Djigma, Kafui Akakpo, Ebenezer Aniakwa-Bonsu, Daniel Amoako-Sakyi, Jacques Simpore and Philippe Mayaud

    Gynecologic Oncology Research and Practice 2017 4:5

    Published on: 3 March 2017

    The Erratum to this article has been published in Gynecologic Oncology Research and Practice 2017 4:8

  4. Case Report

    Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report

    Nivolumab is an immune checkpoint inhibitor specific for the programmed death 1 (PD-1) receptor that has led to clinical responses in many cancer types. Identifying biomarkers predictive of response to PD-1 bl...

    Sarah E. Paraghamian, Teresa C. Longoria and Ramez N. Eskander

    Gynecologic Oncology Research and Practice 2017 4:3

    Published on: 2 February 2017

  5. Review

    Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review

    Merkel cell carcinoma is a rare and aggressive neoplasm originating from mechanoreceptor Merkel cells of the stratum basale of the epidermis. Cases affecting the vulva are exceedingly rare, with the currently ...

    Austin Huy Nguyen, Ahmed I. Tahseen, Adam M. Vaudreuil, Gabriel C. Caponetti and Christopher J. Huerter

    Gynecologic Oncology Research and Practice 2017 4:2

    Published on: 25 January 2017

  6. Research

    Disparities in the surgical staging of high-grade endometrial cancer in the United States

    The National Comprehensive Cancer Network (NCCN) and the Society of Gynecologic Oncology (SGO) recommend lymph node sampling (LNS) as a key component in the surgical staging of high-grade endometrial cancer. O...

    Jonathan R. Foote, Stephanie Gaillard, Gloria Broadwater, Julie A. Sosa, Brittany Davidson, Mohamed A. Adam, Angeles Alvarez Secord, Monica B. Jones, Junzo Chino and Laura J. Havrilesky

    Gynecologic Oncology Research and Practice 2017 4:1

    Published on: 19 January 2017

  7. Research

    Genetic testing in a gynaecological oncology care in developing countries—knowledge, attitudes and perception of Nepalese clinicians

    Genetic testing for an inherited susceptibility to cancer is an emerging technology in medical practice. Little information is currently available about physicians’ attitudes towards these tests in developing ...

    Hanoon P Pokharel, Neville F Hacker and Lesley Andrews

    Gynecologic Oncology Research and Practice 2016 3:12

    Published on: 5 December 2016

  8. Research

    Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis

    Chemotherapy plays a role in the treatment of endometrioid endometrial cancer (EEC); however, tumor grade may affect response. Our objective was to evaluate associations between tumor grade and in vitro chemor...

    Brittany A. Davidson, Jonathan Foote, Stacey L. Brower, Chunqiao Tian, Laura J. Havrilesky and Angeles Alvarez Secord

    Gynecologic Oncology Research and Practice 2016 3:13

    Published on: 1 December 2016

  9. Review

    The role of immune checkpoint inhibition in the treatment of ovarian cancer

    The introduction of immune checkpoint inhibitors has revolutionized treatment of multiple cancers and has bolstered interest in this treatment approach. So far, emerging clinical data show limited clinical eff...

    Stéphanie L. Gaillard, Angeles A. Secord and Bradley Monk

    Gynecologic Oncology Research and Practice 2016 3:11

    Published on: 24 November 2016

  10. Research

    Long term follow-up of a phase II trial of multimodal therapy given in a “sandwich” method for stage III, IV, and recurrent endometrial cancer

    Our objective was to determine if previously reported overall survival (OS) and progression-free survival (PFS) rates are maintained long term following multimodal therapy for advanced and recurrent endometria...

    Michelle Glasgow, Rachel Isaksson Vogel, Jennifer Burgart, Peter Argenta, Kathryn Dusenbery and Melissa A. Geller

    Gynecologic Oncology Research and Practice 2016 3:6

    Published on: 26 May 2016

  11. Research

    Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study

    After platinum and taxane chemotherapy, with or without bevacizumab, active regimens for advanced or recurrent cervical cancer are lacking. Our objective was to review a single institution experience in treati...

    Lindsey E. Minion, Dana M. Chase, John H. Farley, Lyndsay J. Willmott and Bradley J. Monk

    Gynecologic Oncology Research and Practice 2016 3:4

    Published on: 14 April 2016

  12. Review

    New treatment option for ovarian cancer: PARP inhibitors

    Poly(ADP-ribose) polymerase (PARP), which was first described over 50 years ago by Mandel, are a family of protein enzymes involved in DNA damage response and works by recognizing the single-strand DNA break (...

    Robert S. Meehan and Alice P. Chen

    Gynecologic Oncology Research and Practice 2016 3:3

    Published on: 26 February 2016

  13. Research

    Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy

    Many women who develop endometrial cancer (EC) or endometrial hyperplasia with atypia are obese and therefore at high risk of surgical complications. Recently clinical trials have been initiated offering non-s...

    Andreas Obermair, Donal J. Brennan, Eva Baxter, Jane E. Armes, Val Gebski and Monika Janda

    Gynecologic Oncology Research and Practice 2016 3:1

    Published on: 9 February 2016

  14. Case report

    Lumbosacral plexopathy: A rare long term complication of concomitant chemo-radiation for cervical cancer

    Radiation induced Lumbosacral plexophaty (RILP) is a rare but severe complication that has a considerable impact on quality of life. Its occurrence is rare but increasing with improved long-term cancer surviva...

    Imane Bourhafour, Meriem Benoulaid, Hanane El Kacemi, Sanae El Majjaoui, Tayeb Kebdani and Noureddine Benjaafar

    Gynecologic Oncology Research and Practice 2015 2:12

    Published on: 4 December 2015

Previous Page Page 1 of 2 Next Page